Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Blood Advances|January 10, 2022
Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunityHoda Pourhassan, Corinna La Rosa, Flavia Chiuppesi, et al.
Nature Communications|December 1, 2020
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platformFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2020
Development of a Synthetic Poxvirus-Based SARS-CoV-2 VaccineFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Iscience|July 18, 2022
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variantsFlavia Chiuppesi, John A Zaia, Katelyn Faircloth, et al.
JCI Insight|July 7, 2017
Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeysCody S Nelson, Diana Vera Cruz, Dollnovan Tran, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2015
Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmissionKristy M Bialas, Takayuki Tanaka, Dollnovan Tran, et al.
Frontiers in Immunology|March 20, 2023
Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational studyCorinna La Rosa, Flavia Chiuppesi, Yoonsuh Park, et al.
The Lancet. Microbe|March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trialFlavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Vaccines|September 28, 2023
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular TherapyFlavia Chiuppesi, Sandra Ortega-Francisco, Miguel-Angel Gutierrez, et al.
Pageof 4